hero

Join the teams building tomorrow.

Verve Therapeutics
Verve Therapeutics
vervetx.com

Locations

Cambridge, MA, USA · Cambridge, MA, USA · Boston, MA, USA · West Street / River Street, Boston, MA, USA

industry

Biotechnology

Size

201-1000 employees

Stage

IPO

founded in

2018

Verve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics, and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verve’s gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. In 2023, Verve was recognized as a "Best Places to Work" by the Boston Globe. Verve is headquartered in Boston, Massachusetts.

Something looks off?
Open jobs at Verve Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.